Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5798092 | BAYER HLTHCARE | Derivatized DTPA complexes pharmaceutical agents containing these compounds, their use, and processes for their production |
Aug, 2015
(8 years ago) | |
US6039931 | BAYER HLTHCARE | Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production |
Nov, 2021
(2 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
M(M-155) | Mar 27, 2018 |
New Chemical Entity Exclusivity(NCE) | Jul 03, 2013 |
NCE-1 date: 03 July, 2012
Market Authorisation Date: 03 July, 2008
Treatment: Magnetic resonance imaging of the liver
Dosage: SOLUTION;INTRAVENOUS